Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Thomson

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Therapeutic Drug Monitoring|April 1, 1994
Evaluation of a Bayesian approach to the pharmacokinetic interpretation of cyclosporin concentrations in renal allograft recipientsJ E Anderson, A S Munday, A W Kelman, et al.
Clinical Endocrinology|April 18, 2007
Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiencyA H Thomson, M C Devers, A M Wallace, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaireC M Tobin, J M Darville, A H Thomson, et al.
British Medical Journal (Clinical Research Ed.)|February 18, 1984
Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribingB Whiting, A W Kelman, S M Bryson, et al.
British Journal of Clinical Pharmacology|November 1, 1984
Estimation of gentamicin clearance and volume of distribution in neonates and young childrenA W Kelman, A H Thomson, B Whiting, et al.
Thorax|February 1, 2005
BTS guidelines for the management of pleural infection in childrenI M Balfour-Lynn, E Abrahamson, G Cohen, et al.
Forensic Science International|May 12, 2001
A survey of extraction techniques for drugs of abuse in urineJ F Wilson, B L Smith, P A Toseland, et al.
Forensic Science International|August 23, 2001
External quality assessment of laboratory performance in analysis of toxicological casesJ F Wilson, P A Toseland, N E Capps, et al.
Therapeutic Drug Monitoring|June 19, 1998
An audit of therapeutic drug monitoring service provision by laboratories participating in an external quality assessment schemeA H Thomson, I D Watson, J F Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II CommitteeP A Vasey, S B Kaye, R Morrison, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Therapeutic Drug Monitoring|April 1, 1994
Evaluation of a Bayesian approach to the pharmacokinetic interpretation of cyclosporin concentrations in renal allograft recipientsJ E Anderson, A S Munday, A W Kelman, et al.
Clinical Endocrinology|April 18, 2007
Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiencyA H Thomson, M C Devers, A M Wallace, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaireC M Tobin, J M Darville, A H Thomson, et al.
British Medical Journal (Clinical Research Ed.)|February 18, 1984
Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribingB Whiting, A W Kelman, S M Bryson, et al.
British Journal of Clinical Pharmacology|November 1, 1984
Estimation of gentamicin clearance and volume of distribution in neonates and young childrenA W Kelman, A H Thomson, B Whiting, et al.
Thorax|February 1, 2005
BTS guidelines for the management of pleural infection in childrenI M Balfour-Lynn, E Abrahamson, G Cohen, et al.
Forensic Science International|May 12, 2001
A survey of extraction techniques for drugs of abuse in urineJ F Wilson, B L Smith, P A Toseland, et al.
Forensic Science International|August 23, 2001
External quality assessment of laboratory performance in analysis of toxicological casesJ F Wilson, P A Toseland, N E Capps, et al.
Therapeutic Drug Monitoring|June 19, 1998
An audit of therapeutic drug monitoring service provision by laboratories participating in an external quality assessment schemeA H Thomson, I D Watson, J F Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II CommitteeP A Vasey, S B Kaye, R Morrison, et al.
Pageof 9